Recordati Industria Chimica e Farmaceutica S.p.A. (LON: 0KBS)
London
· Delayed Price · Currency is GBP · Price in EUR
58.75
-0.25 (-0.42%)
At close: Jan 31, 2025
Recordati Industria Chimica e Farmaceutica Revenue
Recordati Industria Chimica e Farmaceutica had revenue of 557.41M EUR in the quarter ending September 30, 2024, with 8.89% growth. This brings the company's revenue in the last twelve months to 2.27B, up 11.68% year-over-year. In the year 2023, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.08B with 12.36% growth.
Revenue (ttm)
2.27B EUR
Revenue Growth
+11.68%
P/S Ratio
n/a
Revenue / Employee
509.37K EUR
Employees
4,455
Market Cap
10.05B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.08B | 229.02M | 12.36% |
Dec 31, 2022 | 1.85B | 273.23M | 17.29% |
Dec 31, 2021 | 1.58B | 131.21M | 9.06% |
Dec 31, 2020 | 1.45B | -32.98M | -2.23% |
Dec 31, 2019 | 1.48B | 129.61M | 9.59% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 227.10B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
British American Tobacco p.l.c. | 26.18B |
BP p.l.c. | 144.69B |